Navigation Links
Dr. Fischer Said It Will Notify Pediatricians That Its Baby Eyelid Wipes Are Available At U.S. Pharmacies Contrary To What A Competitor Is Saying In Advertising About Its Wipes For Babies Being The 'First And Only' In The U.S. Market
Date:8/13/2012

NEW YORK, Aug. 13, 2012 /PRNewswire/ -- Dr. Fischer, the global pharmaceutical company based in Israel, said today it will send a letter to Pediatricians, Ophthalmologists and Pharmacists notifying them that its baby eyelid wipes have been available for some time at U.S. pharmacies contrary to what an eye-care competitor is saying in advertising about its baby eyelid & eyelash cleanser being the "first and only" such wipes in the U.S. market.

Not only does it plan to correct the record, but Dr. Fischer will take the opportunity also to point out that no one can miss its brand and world famous logo in pharmacies and that its eye-care wipes for babies individually are not only a superior product according to many pediatricians, but even much larger in size than the competitor's brand. 

"Dr. Fischer's baby eyelid wipes have been available at U.S. pharmacies since December 2008," said Tom Madden, CEO of  Dr. Fischer's public relations firm in the U.S., TransMedia Group (www.transmediagroup.com).   

"The Dr. Fischer eye-care for babies product started out on a small scale at private pharmacies and since June of this year distribution and sales have expanded significantly as more and more pediatricians and pharmacists started recommending Dr. Fischer Baby Eye-Care Wipes as well as other Dr. Fischer eye-care products," Madden said.

"All that Dr. Fischer is seeking to do is to make it known that there is not only one, but two eyelid wipes for children on the market and that Dr. Fischer's product has been available for some time," Madden said. 

"There's no reason why competitors can't compete amicably as long as that what they say about the market is accurate."

About Fischer Pharmaceuticals

Fischer Pharmaceuticals is a world leader in the development and manufacture of advanced health care preparations in the fields of dermatology, opthalmology and nutraceuticals.

The company's innovative R&D continually sets trends and norms in the industry, utilizing its' medical know-how with advanced pharmaceutical technology to offer consumers the best of both worlds; science and nature.

Media contact: Donna Balancia, 561-750-9800 x223 or donna@transmediagroup.com


'/>"/>
SOURCE Fischer Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
2. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
3. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com
5. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
6. FUJIFILM Synapse® Mobility 3.0 Now Available In The U.S.
7. Telescope Implant for End Stage Macular Degeneration Now Available Across the Nation
8. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
10. Cytomedix, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. DATATRAK International, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
Breaking Medicine News(10 mins):